Cargando…
Efficacy and Cost Comparison of Ertapenem as Outpatient Parenteral Antimicrobial Therapy in Acute Pyelonephritis due to Extended-spectrum Beta-lactamase-producing Enterobacteriaceae
Outpatient parenteral antimicrobial therapy (OPAT) programs are becoming an increasingly popular trend in clinical practice as they offer several benefits to both patients and health-care setups. While OPAT is an established clinical practice in the Western world, the concept itself is alien to pati...
Autores principales: | Ramasubramanian, V., Murlidharan, P., Nambi, S., Pavithra, S., Puthran, S., Petigara, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146727/ https://www.ncbi.nlm.nih.gov/pubmed/30270995 http://dx.doi.org/10.4103/ijn.IJN_207_17 |
Ejemplares similares
-
Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms
por: Mody, Rupal M, et al.
Publicado: (2007) -
Retrospective assessment of antimicrobial stewardship initiative in outpatient use of ertapenem for uncomplicated extended spectrum beta lactamase Enterobacteriaceae urinary tract infections
por: Wong, Carrie P., et al.
Publicado: (2021) -
Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae in Fresh Produce
por: Pintor-Cora, Alberto, et al.
Publicado: (2021) -
Effectiveness of oral antibiotics for treating pyelonephritis caused by extended‐spectrum beta‐lactamase‐producing Enterobacteriaceae: A case series
por: Terada, Norihiko, et al.
Publicado: (2020) -
In Vitro Activities of Ertapenem and Imipenem against Clinical Extended Spectrum Beta-Lactamase-Producing Enterobacteriaceae Collected in Military Teaching Hospital Mohammed V of Rabat
por: Elouennass, M., et al.
Publicado: (2012)